A malaria vaccine, deployed in combination with current malaria-control tools, could play an important role in the future control and eventual elimination of malaria in Africa. This article, published in the New England Journal of Medicine, reports the initial results of an ongoing phase 3 trial of RTS,S/AS01 being conducted at 11 centers in seven African countries.
Corporate author(s): The RTS,S Clinical Trials Partnership
Publication date: November 2011
726 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA